Genzyme ends tracking-stock structure
Executive Summary
Genzyme will exchange shares of Genzyme Biosurgery stock and Genzyme Molecular Oncology stock for shares of Genzyme General stock on June 30. "We do not expect to make any major changes within our business or research programs at this time," CEO Henri Termeer says. Termeer was asked about the company's capital structure in light of concerns about tracking stocks and corporate accounting during an April 16 earnings call (1"The Pink Sheet" April 28, In Brief)...
You may also be interested in...
Genzyme reorganization?
Genzyme CEO Henri Termeer was asked several times during April 16 conference call about the company's capital structure in light of recent concerns about tracking stocks and corporate accounting. "We are always looking at the capital structure of the company. We are doing that now and will be looking at doing that in the future," Termeer says. Pressed for further comment, Termeer says, "this is an earnings call, not a structure call"...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.